Latest updates for Lcryx
Fresh curated links around LCRYX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Lyntris files for IPO, plans to list on NYSE under "LYNX"
- Xryma Means "Money" in Greek. Its Euronext Paris Debut Won't Raise Any
- Lord Abbett Core Fixed Income Fund Q2 2026 Commentary
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
financemagnates.com
/1 month ago
Xryma Means "Money" in Greek. Its Euronext Paris Debut Won't Raise Any
Xryma, which was recently rebranded from ISX Financial EU, has received approval from the Cyprus Securities and Exchange Commission for the prospectus governing the admission of it...
seekingalpha.com
/1 week ago
Liquidia: YUTREPIA's Launch Opens Upside If Growth Remains And Margins Follow
fool.com
/1 week ago
Recursion (RXRX) Q2 2026 Earnings Call Transcript
AI-native drug discovery advances neuroscience target with Roche while cutting cash guidance.
seekingalpha.com
/4 weeks ago
Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions
seekingalpha.com
/5 days ago
The Lottery Corporation Limited (LTRCF) Q4 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
PLS Group: The Lithium Cycle Is Turning Toward The Scaled Survivor
seekingalpha.com
/2 weeks ago
Recursion Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/5 days ago
X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade)
finance.yahoo.com
/5 days ago
AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
seekingalpha.com
/3 weeks ago
Elixir Energy Limited (ELXPF) Shareholder/Analyst Call - Slideshow
seekingalpha.com
/1 month ago
Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin
fool.com
/1 week ago
Ultragenyx (RARE) Q2 2026 Earnings Call Transcript
Record revenue of $214 million signals momentum ahead of gene therapy launches.
seekingalpha.com
/1 month ago
LSI Industries: Lights-Out Performance Caught Up With Fundamentals (Downgrade)
seekingalpha.com
/2 weeks ago
ERC: Managed 8.75% Distribution Policy With Monthly Pay And Fixed-Income Exposure
seekingalpha.com
/1 month ago
Critical Rare Earth Race To Accelerate As China Tightens Grip
fool.com
/1 week ago
Circle (CRCL) Q2 2026 Earnings Call Transcript
USDC circulation hit $73.3 billion as Arc blockchain prepares for mainnet launch.
seekingalpha.com
/3 weeks ago
argenx: Upgrading To Buy, The VYVGART Growth Cycle Has Further To Go
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Lcryx
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
financemagnates.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source